Accession Number: | 0001790300-21-000010 |
Date: | 2021-07-22 |
Issuer: | RESHAPE LIFESCIENCES INC. (RSLS) |
Original Submission Date: |
STANKOVICH THOMAS
1001 CALLE AMANECER
SAN CLEMENTE, CA 92673
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.001 PAR VALUE PER SHARE | 2021-07-22 | A | 282,382 | a | $0.00 | 315,995 | direct | ||
COMMON STOCK, $0.001 PAR VALUE PER SHARE | 2021-07-22 | A | 90,362 | a | $0.00 | 406,357 | direct | ||
COMMON STOCK, $0.001 PAR VALUE PER SHARE | 2021-09-10 | S | 48,366 | d | $2.89 | 357,991 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | these shares will vest and be issued with respect to 123,542 shares on july 22, 2021 and the remaining shares vesting monthly thereafter for 36 months pursuant to a restricted stock unit granted under the reshape lifesciences inc. second amended and restated 2003 stock incentive plan. |
f2 | these shares will vest and be issued monthly over 36 months beginning on july 22, 2021 pursuant to a restricted stock unit granted under the reshape lifesciences inc. second amended and restated 2003 stock incentive plan. |
f3 | these shares were sold to cover taxes in connection with the vesting of restricted stock units. |
f4 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. the reporting person undertakes to provide to reshape lifesciences inc., any security holder of reshape lifesciences inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this form 4. |